Zellweger Syndrome - SP Medifort Hospital

Zellweger Syndrome Treatment

Zellweger Syndrome Disease: Diagnosis, Management, and Treatment

Zellweger syndrome is a rare inherited peroxisomal disorder that affects brain development, liver function, and multiple organ systems, usually presenting in the newborn period. Early recognition and coordinated medical support are essential for improving quality of life. SP Medifort Hospital provides structured Zellweger syndrome diagnosis and care in South India through a multidisciplinary pediatric and metabolic care approach. Our team includes the best pediatric genetic disorder specialists in Kerala, offering advanced evaluation and supportive management for complex inherited conditions.

Symptoms and Causes

Symptoms of Zellweger syndrome

Symptoms usually appear soon after birth and affect multiple organs.Symptoms of Zellweger syndrome include:

Vision and hearing loss.
Distinctive facial features.
Weak muscle tone (hypotonia).
Seizures.
Enlarged liver (hepatomegaly).
Jaundice.
Kidney abnormalities.

Causes of Zellweger syndrome

Zellweger syndrome is caused by inherited genetic mutations that prevent the normal formation and function of peroxisomes, essential cell structures for breaking down fats and toxins.

Mutations in PEX genes: This condition occurs when there are mutations in one of the PEX genes (such as PEX1, PEX2, PEX3, PEX5, PEX6, etc.), which encode peroxins needed to build and maintain peroxisomes. Without these proteins, peroxisomes cannot form or work properly. Mutations in PEX1 are the most common cause.
Autosomal recessive inheritance: Zellweger syndrome follows an autosomal recessive pattern, meaning a child must inherit two mutated gene copies (one from each parent) to develop the disease, while carriers (with one copy) typically have no symptoms.
Defective peroxisome biogenesis: Because these gene mutations disrupt peroxisome biogenesis, cells lack functional peroxisomes needed for metabolizing very long‑chain fatty acids and detoxifying harmful compounds, leading to the accumulation of toxic substances.

Diagnosis of Zellweger syndrome

Accurate diagnosis involves clinical assessment, metabolic screening, genetic testing, and imaging studies. As part of Zellweger syndrome diagnosis and treatment in South India, evaluation may include:

Clinical Evaluation (Physical Signs): Doctors initially suspect Zellweger syndrome based on characteristic features in newborns—such as distinctive facial appearance, poor muscle tone (hypotonia), feeding difficulties, and neurological signs like seizures.
Biochemical Tests (Blood & Urine): Blood and urine tests check for abnormally elevated very long-chain fatty acids (VLCFAs) and other metabolic markers that reflect peroxisomal dysfunction. These biochemical abnormalities support the diagnosis.
Imaging tests: Ultrasound and MRI assess internal organs (like the liver, kidneys, and brain) for characteristic abnormalities.
Genetic Testing (PEX Genes): The definitive diagnosis is confirmed with genetic testing that identifies pathogenic mutations in the PEX genes, which are responsible for peroxisome biogenesis. This also informs family counseling and future prenatal testing.

Care is guided by a rare genetic disease specialist for Zellweger syndrome along with pediatric neurologists and metabolic experts to confirm diagnosis and plan ongoing management.

What are the Zellweger syndrome risk factors?

Zellweger syndrome is a rare, inherited genetic disorder that occurs when a child inherits defective copies of certain genes from both parents.

Autosomal recessive inheritance: A child must receive a mutated gene from both parents to develop the condition
Gene mutations: Mutations in any of several PEX genes (most often PEX1) disrupt peroxisome formation, leading to the disorder.
Carrier parents: Each pregnancy has a 25% chance of the child being affected if both parents are carriers.

What treatment options are available for Zellweger syndrome?

While there is currently no definitive cure, treatment options are available for Zellweger syndrome to manage symptoms and support organ function. Management focuses on genetic metabolic disorder care and supportive therapy tailored to each child’s needs.

Supportive Symptom Management: Care involves a multidisciplinary team to address feeding, muscle weakness, seizures, and organ dysfunction. This includes physical support, palliative care, and routine monitoring.

Seizure & Symptom Medications: Antiepileptic drugs control seizures, and hormone/vitamin supplements (like vitamins A, D, E, and K) help correct deficiencies caused by metabolic abnormalities.

Sensory Aids & Surgeries: Hearing aids/implants and vision support (glasses or cataract surgery) are used to manage sensory impairments.

Bile Acid Therapy (Cholic Acid): Cholic acid (FDA-approved therapy) may improve liver function and reduce toxic bile acid buildup in patients with peroxisomal dysfunction, though benefits vary and neurologic symptoms may persist.

Experimental & Future Approaches: Research in gene therapy, stem cell theray, and enzyme precursors is ongoing but not yet standard or proven treatments.

SP Medifort Hospital offers integrated peroxisomal disorder treatment and long-term pediatric support through multidisciplinary clinics. With access to the best pediatric genetic disorder specialists in Kerala and advanced diagnostic services, families receive continuous counseling, monitoring, and care planning for rare inherited disorders.